يعرض 1 - 10 نتائج من 99 نتيجة بحث عن '"ACE I/D POLYMORPHISM"', وقت الاستعلام: 1.36s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المصدر: Siberian journal of oncology; Том 22, № 2 (2023); 85-92 ; Сибирский онкологический журнал; Том 22, № 2 (2023); 85-92 ; 2312-3168 ; 1814-4861

    وصف الملف: application/pdf

    العلاقة: https://www.siboncoj.ru/jour/article/view/2536/1098Test; Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classifcation of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2): 97–109. doi:10.1007/s00401-007-0243-4. Erratum in: Acta Neuropathol. 2007; 114(5): 547.; Tan A.C., Ashley D.M., López G.Y., Malinzak M., Friedman H.S., Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020; 70(4): 299–312. doi:10.3322/caac.21613.; Rock K., McArdle O., Forde P., Dunne M., Fitzpatrick D., O’Neill B., Faul C. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival? Br J Radiol. 2012; 85(1017): 729–33. doi:10.1259/bjr/83796755.; Ohgaki H., Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007; 170(5): 1445–53. doi:10.2353/ajpath.2007.070011.; Ostrom Q.T., Patil N., Cioff G., Waite K., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020; 22(12 Suppl 2): 1–96. doi:10.1093/neuonc/noaa200. Erratum in: Neuro Oncol. 2022; 24(7): 1214.; Thakkar J.P., Dolecek T.A., Horbinski C., Ostrom Q.T., Lightner D.D., Barnholtz-Sloan J.S., Villano J.L. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10): 1985–96. doi:10.1158/1055-9965.EPI-14-0275.; Ohka F., Natsume A., Wakabayashi T. Current trends in targeted therapies for glioblastoma multiforme. Neurol Res Int. 2012. doi:10.1155/2012/878425.; O’Rawe M., Kilmister E.J., Mantamadiotis T., Kaye A.H., Tan S.T., Wickremesekera A.C. The rennin-angiotensin system in the tumor microenvironment of glioblastoma. Cancers. 2021; 13(16): 4004. doi:10.3390/cancers13164004.; Nakagawa P., Gomez J., Grobe J.L., Sigmund C.D. The renin-angiotensin system in the central nervous system and its role in blood pressure regulation. Current hypertension reports. 2020; 22(1): 1–10.; Jackson L., Eldahshan W., Fagan S.C., Ergul A. Within the Brain: The Renin Angiotensin System. Int J Mol Sci. 2018; 19(3): 876. doi:10.3390/ijms19030876.; Labandeira-Garcia J.L., Rodríguez-Perez A.I., GarridoGil P., Rodriguez-Pallares J., Lanciego J.L., Guerra M.J. Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration. Front Aging Neurosci. 2017; 9: 129. doi:10.3389/fnagi.2017.00129.; Xu Q., Jensen D.D., Peng H., Feng Y. The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure. Pharmacol Ther. 2016; 164: 126–34. doi:10.1016/j.pharmthera.2016.04.006.; Riquier-Brison A.D.M., Sipos A., Prókai Á., Vargas S.L., Toma L., Meer E.J., Villanueva K.G., Chen J.C.M., Gyarmati G., Yih C., Tang E., Nadim B., Pendekanti S., Garrelds I.M., Nguyen G., Danser A.H.J., Peti-Peterdi J. The macula densa prorenin receptor is essential in renin release and blood p ressure control. Am J Physiol Renal Physiol. 2018; 315(3): 521–34. doi:10.1152/ajprenal.00029.2018.; Bodiga V.L., Bodiga S. Renin angiotensin system in cognitive function and dementia. Asian J Neurosci. 2013. Article ID 102602. doi:10.1155/2013/102602.; Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A frst step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631–7. doi:10.1002/path.1570.; Cui C., Xu P., Li G., Qiao Y., Han W., Geng C., Liao D., Yang M., Chen D., Jiang P. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol. 2019; 26. doi:10.1016/j.redox.2019.101295.; Balyasnikova I.V., Metzger R., Sun Z.L., Berestetskaya Y.V., Albrecht R.F., Danilov S.M. Development and characterization of rat monoclonal antibodies to denatured mouse angiotensinconverting enzyme. Tissue Antigens. 2005; 65(3): 240–51. doi:10.1111/j.1399-0039.2005.00364.x.; Nakagawa P., Sigmund C.D. How Is the Brain ReninAngiotensin System Regulated? Hypertension. 2017; 70(1): 10–8. doi:10.1161/HYPERTENSIONAHA.117.08550.; Ziaja M., Urbanek K.A., Kowalska K., PiastowskaCiesielska A.W. Angiotensin II and Angiotensin Receptors 1 and 2-Multifunctional System in Cells Biology, What Do We Know? Cells. 2021; 10(2): 381. doi:10.3390/cells10020381.; Bradshaw A.R., Wickremesekera A.C., Brasch H.D., Chibnall A.M., Davis P.F., Tan S.T., Itinteang T. Glioblastoma Multiforme Cancer Stem Cells Express Components of the ReninAngiotensin System. Front Surg. 2016; 3: 51. doi:10.3389/fsurg.2016.00051.; Kouchi M., Shibayama Y., Ogawa D., Miyake K., Nishiyama A., Tamiya T. (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway. J Neurosurg. 2017; 127(4): 819–28. doi:10.3171/2016.9.JNS16431.; Hicks B.M., Filion K.B., Yin H., Sakr L., Udell J.A., Azoulay L. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study. BMJ. 2018; 363. doi:10.1136/bmj.k4209.; Moghimi M., Kargar S., Jafari M.A., Ahrar H., Jarahzadeh M.H., Neamatzadeh H., Sadeghizadeh-Yazdi J. Angi- otensin Converting Enzyme Insertion/Deletion Polymorphism is Associated with Breast Cancer Risk: A Meta-Analysis. Asian Pac J Cancer Prev. 2018; 19(11): 3225–31. doi:10.31557/APJCP.2018.19.11.3225.; Wang Z.Y., Li H.Y., Jiang Z.P., Zhou T.B. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility. J Cancer Res Ther. 2018; 14(S): 375–80. doi:10.4103/0973-1482.171366.; Pabalan N., Jarjanazi H., Ozcelik H. Associations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis. J Gastrointest Cancer. 2015; 46(4): 370–9. doi:10.1007/s12029-015-9754-8.; Röcken C., Lendeckel U., Dierkes J., Westphal S., CarlMcGrath S., Peters B., Krüger S., Malfertheiner P., Roessner A., Ebert M.P. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/ deletion polymorphism. Clin Cancer Res. 2005; 11(7): 2526–30. doi:10.1158/1078-0432.CCR-04-1922.; Vairaktaris E., Yapijakis C., Tsigris C., Vassiliou S., Derka S., Nkenke E., Spyridonidou S., Vylliotis A., Vorris E., Ragos V., Neukam F.W., Patsouris E. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol. 2007; 46(8): 1097–102. doi:10.1080/02841860701373579.; Kitsios G., Zintzaras E. ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. BMC Med Genet. 2009; 10: 50. doi:10.1186/1471-2350-10-50.; Haiman C.A., Henderson S.O., Bretsky P., Kolonel L.N., Henderson B.E. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res. 2003; 63(20): 6984–7.; Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86(4): 1343–6. doi:10.1172/JCI114844.; Jeunemaitre X. Genetics of the human renin angiotensin system. J Mol Med (Berl). 2008; 86(6): 637–41. doi:10.1007/s00109-008-0344-0.; Suehiro T., Morita T., Inoue M., Kumon Y., Ikeda Y., Hashi- moto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet. 2004; 115(2): 91–6. doi:10.1007/s00439-004-1136-4.; Holland E.C. Glioblastoma multiforme: the termina- tor. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97(12): 6242–4. doi:10.1073/pnas.97.12.6242.; Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., DePinho R.A. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001; 15(11): 1311–33. doi:10.1101/gad.891601.; Schwartzbaum J.A., Fisher J.L., Aldape K.D., Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006; 2(9): 494–503. doi:10.1038/ncpneuro0289.; Agnihotri S., Burrell K.E., Wolf A., Jalali S., Hawkins C., Rutka J.T., Zadeh G. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch Immunol Ther Exp (Warsz). 2013; 61(1): 25–41. doi:10.1007/s00005-012-0203-0.; Ostrom Q.T., Gittleman H., Truitt G., Boscia A., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro Oncol. 2018; 20(s4):1–86. doi:10.1093/neuonc/noy131. Erratum in: Neuro Oncol. 2018.; Lian M., Jiang H., Wang H., Guo S. Angiotensinconverting enzyme insertion/deletion gene polymorphisms is associated with risk of glioma in a Chinese population. J Renin Angiotensin Aldosterone Syst. 2015; 16(2): 443–7. doi:10.1177/1470320313495910.; Pandith A.A., Qasim I., Zahoor W., Shah P., Bhat A.R. ACE I/D sequence variants but not MTHFR C677T, is strongly linked to malignant glioma risk and its variant DD genotype may act as a promising predictive biomarker for overall survival of glioma patients. Gene. 2018; 639: 62–8. doi:10.1016/j.gene.2017.10.013.; Benenemissi I.H., Sifi K., Sahli L.K., Semmam O., Abadi N., Satta D. Angiotensin-converting enzyme insertion/ deletion gene polymorphisms and the risk of glioma in an Algerian population. Pan Afr Med J. 2019; 32: 197. doi:10.11604/pamj.2019.32.197.15129.; Sun M., Fang Y., Ma S., Gao X., Sun Y. The genetic polymorphisms of angiotensin converting enzyme insertion/deletion and glioma susceptibility: A meta-analysis. J Renin Angiotensin Al- dosterone Syst. 2020; 21(4). doi:10.1177/1470320320963939.; https://www.siboncoj.ru/jour/article/view/2536Test

  6. 6
    دورية أكاديمية
  7. 7
  8. 8
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية